GR3014937T3 - Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes. - Google Patents

Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes.

Info

Publication number
GR3014937T3
GR3014937T3 GR950400201T GR950400201T GR3014937T3 GR 3014937 T3 GR3014937 T3 GR 3014937T3 GR 950400201 T GR950400201 T GR 950400201T GR 950400201 T GR950400201 T GR 950400201T GR 3014937 T3 GR3014937 T3 GR 3014937T3
Authority
GR
Greece
Prior art keywords
human
preparation
treatment
chelating
propylmethylcellulose
Prior art date
Application number
GR950400201T
Other languages
English (en)
Inventor
Shambhu Dayal Varma
Original Assignee
Vision Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25417752&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3014937(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vision Pharma Inc filed Critical Vision Pharma Inc
Publication of GR3014937T3 publication Critical patent/GR3014937T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
GR950400201T 1986-09-04 1995-02-01 Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes. GR3014937T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/903,597 US5032392A (en) 1986-09-04 1986-09-04 Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes

Publications (1)

Publication Number Publication Date
GR3014937T3 true GR3014937T3 (en) 1995-05-31

Family

ID=25417752

Family Applications (2)

Application Number Title Priority Date Filing Date
GR90400840T GR3001098T3 (en) 1986-09-04 1990-11-23 Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
GR950400201T GR3014937T3 (en) 1986-09-04 1995-02-01 Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR90400840T GR3001098T3 (en) 1986-09-04 1990-11-23 Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes

Country Status (9)

Country Link
US (1) US5032392A (el)
EP (1) EP0258865B2 (el)
JP (1) JPH0751500B2 (el)
AT (1) ATE58475T1 (el)
AU (1) AU599695B2 (el)
CA (1) CA1341393C (el)
DE (1) DE3766322D1 (el)
GR (2) GR3001098T3 (el)
IN (1) IN165608B (el)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
US5204331A (en) * 1990-06-29 1993-04-20 Santen Pharmaceutical Co., Ltd. Composition for debridement of retained lens materials
JP3256997B2 (ja) * 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤
US5505953A (en) 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
EP0639070B2 (en) * 1992-05-06 2010-09-08 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
US5830508A (en) 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5382599A (en) * 1993-10-13 1995-01-17 Allergan, Inc. Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent
US5494817A (en) * 1993-12-06 1996-02-27 Allergan, Inc. Sugar-based protease composition for use with constant-PH borate buffers
EP0672414B1 (en) * 1994-03-15 2005-06-08 Senju Pharmaceutical Co., Ltd. Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
CA2199610A1 (en) * 1994-09-14 1996-03-21 Taisho Pharmaceutical Co., Ltd. Eye drops for repairing repairing corneal damage
US6113894A (en) * 1995-01-23 2000-09-05 Smith; S. Gregory Ophthalmic compositions and process of using
US5861148A (en) * 1995-01-23 1999-01-19 Smith; Stewart Gregory Ophthalmic compositions and process of using
DE19511322C2 (de) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
US5783407A (en) * 1996-04-05 1998-07-21 Beckman Instruments, Inc. Method of measuring bilirubin
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
US6726922B1 (en) 1999-06-28 2004-04-27 Minu, L.L.C. Process and composition for temporarily suppressing pain
JP2001158734A (ja) * 1999-12-02 2001-06-12 Lion Corp 眼科用組成物及びソフトコンタクトレンズに対する吸着抑制方法
JP4713706B2 (ja) * 2000-03-14 2011-06-29 テルモ株式会社 脂溶性ビタミン可溶化液入り容器
JP2004502497A (ja) * 2000-07-12 2004-01-29 ルージュ　ヴァリー　ナチュラル　スプリングス　インコーポレイテッド 眼の表面を湿らせる方法及びキット
US7524511B1 (en) * 2000-07-12 2009-04-28 Rogue Valley Natural Springs, Inc. Method and kit for moisturizing the surface of the eye
EP1207208A3 (en) * 2000-11-15 2003-12-10 Becton Dickinson and Company Method for preservation of cells and nucleic acid targets
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
WO2002049613A2 (en) * 2000-12-19 2002-06-27 Bausch & Lomb Incorporated Method for enhancing integrity of epithelium using retinoic acid
SE520715C2 (sv) * 2001-12-03 2003-08-12 Akzo Nobel Nv Förfarande för framställning av metylcellulosaetrar
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
US20050065091A1 (en) * 2003-09-18 2005-03-24 Gholam Peyman Stabilized ocular solutions
KR20070091283A (ko) 2004-11-04 2007-09-10 시리온 테라퓨틱스, 인크. 레티놀-레티놀 결합단백질(ｒｂｐ)-트랜스타이레틴(ｔｔｒ) 복합체 형성의조절 인자
EP1988936B1 (en) * 2006-02-17 2014-08-06 Novartis AG Ophtalmic product and method for sterilization
ES2396999T3 (es) * 2007-05-04 2013-03-01 Bausch & Lomb Incorporated Composiciones para la reducción, mejora, tratamiento, o prevención de la afección de ojo seco y métodos de elaboración y de uso de las mismas
US10383839B2 (en) 2011-06-30 2019-08-20 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
JP6179204B2 (ja) * 2012-06-08 2017-08-16 ライオン株式会社 粘膜用組成物及びその製造方法
US9687481B2 (en) 2013-01-23 2017-06-27 Aldeyra Therapeutics, Inc. Toxic aldehyde related diseases and treatment
CA2899339C (en) * 2013-02-01 2021-07-06 Ocularis Pharma, Llc Aqueous ophthalmic solutions of phentolamine and medical uses thereof
AU2014212275B2 (en) 2013-02-01 2018-09-06 Ocuphire Pharma, Inc. Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
ES2669446B1 (es) * 2016-11-24 2019-03-13 Saiz Manuel Munoz Producto oftálmico
CN111386337A (zh) * 2017-11-24 2020-07-07 Gtreebnt科技有限公司 包含胸腺素β4或其衍生物作为活性成分的用于促进杯状细胞增殖或粘蛋白分泌的组合物
CN112714762A (zh) 2018-08-06 2021-04-27 奥尔德拉医疗公司 多晶型化合物及其用途
JP2022505950A (ja) 2018-10-26 2022-01-14 オキュフィア・ファーマ・インコーポレイテッド 老眼、散瞳、および他の眼障害の治療のための方法および組成物
JP2022526917A (ja) 2019-03-26 2022-05-27 アルデイラ セラピューティクス， インコーポレイテッド 眼科用製剤およびその使用
EP3962894A4 (en) 2019-05-02 2023-01-11 Aldeyra Therapeutics, Inc. POLYMORPHIC COMPOUNDS AND USES THEREOF
WO2021231792A1 (en) 2020-05-13 2021-11-18 Aldeyra Therapeutics, Inc. Pharmaceutical formulations and uses thereof
CN115368310A (zh) 2021-05-18 2022-11-22 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3384545A (en) * 1965-03-09 1968-05-21 Hoffmann La Roche Injectable aqueous emulsions of fat soluble vitamins
GB1431841A (en) * 1973-01-15 1976-04-14 Evans S C Ophthalmic-nutritional preparations
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4219545A (en) * 1979-03-23 1980-08-26 Collins Calvin E Treatment of infectious keratoconjunctivitis in animals
DE3271414D1 (en) * 1981-10-09 1986-07-03 Baylor College Medicine Use of methotrexate and/or retinoic acid for the manufacture of compositions for use in preventing proliferation of remnant lens epithelial cells after extracapsular extraction
US4515794A (en) * 1981-10-09 1985-05-07 Baylor College Of Medicine Mitotic inhibitors preventing posterior lens capsule opacification
US4421748A (en) * 1982-07-13 1983-12-20 Trager Seymour F Artificial tear aid

Also Published As

Publication number Publication date
AU7797887A (en) 1988-03-10
CA1341393C (en) 2002-10-15
EP0258865B2 (en) 1995-01-04
DE3766322D1 (de) 1991-01-03
US5032392A (en) 1991-07-16
EP0258865B1 (en) 1990-11-22
AU599695B2 (en) 1990-07-26
JPS63208516A (ja) 1988-08-30
IN165608B (el) 1989-11-25
EP0258865A3 (en) 1989-03-08
EP0258865A2 (en) 1988-03-09
ATE58475T1 (de) 1990-12-15
GR3001098T3 (en) 1992-04-17
JPH0751500B2 (ja) 1995-06-05

Similar Documents

Publication Publication Date Title
GR3014937T3 (en) Aqueous opthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes.
US5585406A (en) Nonirritating nonionic tissue cleaning method
IL82615A0 (en) Aqueous steroid formulations for nasal administration
HU900591D0 (en) Regulated agent-dissolving safety system and process of it's preparation
JPH11199899A (ja) コンタクトレンズ用液およびそれを用いたコンタクトレンズの洗浄方法
WO1991015200A3 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
FR2833493B1 (fr) Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
JP2002524418A (ja) 眼用組成物および使用法
EP0255967B1 (en) Method of treating contact lenses
IE821566L (en) Composition for topical application to skin
US4692262A (en) Skin cleanser capable of softening and removing smegma
JPS6442424A (en) Ophthalmic solution
AU1217392A (en) Corneal treatment agents
DK0741579T3 (da) Vandig formulering med forhalet frigivelse
JPS568324A (en) Infectious disease remedy for external and ophthalmologic application
Kawai et al. The Influence of surfactants upon the skin IV The influence of Sodium Lauryl Sulfate upon the skin
CA2243824A1 (en) Therapeutic agent for keratoconjunctiva diseases
EP0456988A3 (en) Use of naproxen as mydriatic agent
ES512751A0 (es) "procedimiento para la preparacion de un colirio antiseptico para afecciones oculares".